We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Antibodies – Webinars and Online Events

Refyen
Webinar

Advancing mAb Stability Studies With Mass Photometry

On-Demand
In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics.
SCIEX - Antibodies
Webinar

Characterization of Sequence Modifications in Monoclonal Antibodies

On-Demand
In this webinar, our expert speaker will discuss how these complementary techniques can be performed on the ZenoTOF instrument to localize modifications on therapeutic mAbs.
Novel Therapeutics
Webinar

Novel Purification Approaches To Streamline Manufacturing of Antibody-Based Therapeutics

On-Demand
The global market for antibody therapeutics is rising rapidly and newer, engineered modalities such as bi-specific antibodies and antibody fragments are entering clinical studies in record numbers.
Antibody Ed Cal webinar by Technology Networks, 27th July at 4pm BST
Webinar

Machine Learning Methods for De Novo Antibody Design

On-Demand
In this webinar, our expert speaker Dr. Phillip Kim from the University of Toronto will be discussing the ML methods he currently implements in his lab that enables de novo antibody design. He will also cover ML-based sequence design and scoring methods, as well as diffusion models.
High-Throughput Charge Variant Analysis of Therapeutic Proteins content piece image
Webinar

High-Throughput Charge Variant Analysis of Therapeutic Proteins

On-Demand
Charge heterogeneity is often a critical quality attribute, which must be monitored throughout the development of a therapeutic protein and during quality control release.
Innovative Strategies for Therapeutic Antibody Development and Production content piece image
Webinar

Innovative Strategies for Therapeutic Antibody Development and Production

On-Demand
This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.
The Importance of High-Resolution Ion Mobility Mass Spectrometry to Accurately Read Back the Complex Language of Biology content piece image
Webinar

The Importance of High-Resolution Ion Mobility Mass Spectrometry to Accurately Read Back the Complex Language of Biology

On-Demand
This webinar discusses an analytical approach for N-linked glycan analysis using the SLIM-based high-resolution ion mobility platform MOBIE. Results will be shown for each aspect of the overall strategy and how this platform can be an integral part for the characterization of protein therapeutics.
SARS-CoV-2–Specific B Cell Detection and Therapeutic Antibody Discovery content piece image
Webinar

SARS-CoV-2–Specific B Cell Detection and Therapeutic Antibody Discovery

On-Demand
To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential.
Comprehensive Analysis of Next-Generation Biologics content piece image
Webinar

Comprehensive Analysis of Next-Generation Biologics

On-Demand
New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.
Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics content piece image
Webinar

Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics

On-Demand
Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame.
Advertisement